TABLE 5.
Association Between Race/Ethnicity and SVR Among Genotype 1 Patients Treated With 8 Versus 12 Weeks of LDV/SOF
| Genotype 1 LDV/SOF 8 weeks |
||||
|---|---|---|---|---|
| Crude Odds Ratio |
P | AOR* | P | |
| White | 1 | 1 | ||
| Black | 0.44 | <0.001 | 0.56 | 0.01 |
| Hispanic | 0.76 | 0.7 | 0.71 | 0.6 |
| Asian/PI/AI/AN | 0.52 | 0.4 | 0.60 | 0.5 |
| Declined/missing | 0.53 | 0.04 | 0.63 | 0.2 |
| Genotype 1 LDV/SOF | 12 weeks | |||
| White | 1 | 1 | ||
| Black | 0.93 | 0.7 | 0.89 | 0.5 |
| Hispanic | 0.71 | 0.4 | 0.79 | 0.5 |
| Asian/PI/AI/AN | 0.72 | 0.6 | 1.08 | 0.9 |
| Declined/missing | 0.67 | 0.07 | 0.69 | 0.1 |
*
Adjusted by multivariable logistic regression modeling including race/ethnicity, age, gender, HCV viral load, platelet count, serum bilirubin level, serum albumin level, alcohol use disorder, diabetes, cirrhosis, decompensated cirrhosis, HCC, liver transplantation, and prior treatment.